{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:37:29Z","timestamp":1791113849605,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"48","license":[{"start":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T00:00:00Z","timestamp":1328486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T00:00:00Z","timestamp":1328486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,11,29]]},"DOI":"10.1038\/onc.2012.13","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T13:58:28Z","timestamp":1328536708000},"page":"4996-5006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL"],"prefix":"10.1038","volume":"31","author":[{"given":"G L","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Dinsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,6]]},"reference":[{"key":"BFonc201213_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O . On respiratory impairment in cancer cells. Science 1956; 124: 269\u2013270.","journal-title":"Science"},{"key":"BFonc201213_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc882","volume":"2","author":"SS Gambhir","year":"2002","unstructured":"Gambhir SS . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2: 683\u2013693.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201213_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB . The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2007; 7: 11\u201320.","journal-title":"Cell Metab"},{"key":"BFonc201213_CR4","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Martin DS, Xu RH, Huang P . Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25: 4633\u20134646.","journal-title":"Oncogene"},{"key":"BFonc201213_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0968-0004(01)01844-8","volume":"26","author":"C Adrain","year":"2001","unstructured":"Adrain C, Martin SJ . The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 2001; 26: 390\u2013397.","journal-title":"Trends Biochem Sci"},{"key":"BFonc201213_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0300-9084(02)01376-7","volume":"84","author":"K Cain","year":"2002","unstructured":"Cain K, Bratton SB, Cohen GM . The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 2002; 84: 203\u2013214.","journal-title":"Biochimie"},{"key":"BFonc201213_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.immunol.17.1.331","volume":"17","author":"D Wallach","year":"1999","unstructured":"Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP . Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17: 331\u2013367.","journal-title":"Annu Rev Immunol"},{"key":"BFonc201213_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"SR Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673\u2013682.","journal-title":"Immunity"},{"key":"BFonc201213_CR9","doi-asserted-by":"publisher","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","volume":"271","author":"RM Pitti","year":"1996","unstructured":"Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A . Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687\u201312690.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157\u2013163.","journal-title":"Nat Med"},{"key":"BFonc201213_CR11","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1200\/JCO.2007.13.1011","volume":"25","author":"MJ Dyer","year":"2007","unstructured":"Dyer MJ, MacFarlane M, Cohen GM . Barriers to effective TRAIL-targeted therapy of malignancy. J Clin Oncol 2007; 25: 4505\u20134506.","journal-title":"J Clin Oncol"},{"key":"BFonc201213_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nrc821","volume":"2","author":"A Ashkenazi","year":"2002","unstructured":"Ashkenazi A . Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002; 2: 420\u2013430.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201213_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2567.2009.03058.x","volume":"127","author":"C Falschlehner","year":"2009","unstructured":"Falschlehner C, Schaefer U, Walczak H . Following TRAIL's path in the immune system. Immunology 2009; 127: 145\u2013154.","journal-title":"Immunology"},{"key":"BFonc201213_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2009.06.012","volume":"35","author":"MA Hughes","year":"2009","unstructured":"Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M . Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 2009; 35: 265\u2013279.","journal-title":"Mol Cell"},{"key":"BFonc201213_CR15","doi-asserted-by":"publisher","first-page":"22532","DOI":"10.1074\/jbc.274.32.22532","volume":"274","author":"C Scaffidi","year":"1999","unstructured":"Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME . Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 1999; 274: 22532\u201322538.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR16","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/sj.onc.1205258","volume":"21","author":"S Fulda","year":"2002","unstructured":"Fulda S, Meyer E, Debatin KM . Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 2002; 21: 2283\u20132294.","journal-title":"Oncogene"},{"key":"BFonc201213_CR17","doi-asserted-by":"publisher","first-page":"29652","DOI":"10.1074\/jbc.M603487200","volume":"281","author":"AK Samraj","year":"2006","unstructured":"Samraj AK, Keil E, Ueffing N, Schulze-Osthoff K, Schmitz I . Loss of caspase-9 provides genetic evidence for the type I\/II concept of CD95-mediated apoptosis. J Biol Chem 2006; 281: 29652\u201329659.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm0302-274","volume":"8","author":"H LeBlanc","year":"2002","unstructured":"LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P et al. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002; 8: 274\u2013281.","journal-title":"Nat Med"},{"key":"BFonc201213_CR19","first-page":"2057","volume":"53","author":"NS Thakkar","year":"1993","unstructured":"Thakkar NS, Potten CS . Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-D-glucose. Cancer Res 1993; 53: 2057\u20132060.","journal-title":"Cancer Res"},{"key":"BFonc201213_CR20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1084\/jem.188.5.979","volume":"188","author":"D Ferrari","year":"1998","unstructured":"Ferrari D, Stepczynska A, Los M, Wesselborg S, Schulze-Osthoff K . Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med 1998; 188: 979\u2013984.","journal-title":"J Exp Med"},{"key":"BFonc201213_CR21","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","volume":"185","author":"M Leist","year":"1997","unstructured":"Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P . Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481\u20131486.","journal-title":"J Exp Med"},{"key":"BFonc201213_CR22","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.cdd.4401661","volume":"12","author":"MV Zamaraeva","year":"2005","unstructured":"Zamaraeva MV, Sabirov RZ, Maeno E, Ando-Akatsuka Y, Bessonova SV, Okada Y . Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death Differ 2005; 12: 1390\u20131397.","journal-title":"Cell Death Differ"},{"key":"BFonc201213_CR23","first-page":"444","volume":"55","author":"HD Halicka","year":"1995","unstructured":"Halicka HD, Ardelt B, Li X, Melamed MM, Darzynkiewicz Z . 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res 1995; 55: 444\u2013449.","journal-title":"Cancer Res"},{"key":"BFonc201213_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.onc.1205068","volume":"21","author":"SY Nam","year":"2002","unstructured":"Nam SY, Amoscato AA, Lee YJ . Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene 2002; 21: 337\u2013346.","journal-title":"Oncogene"},{"key":"BFonc201213_CR25","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.1074\/jbc.M212392200","volume":"278","author":"C Munoz-Pinedo","year":"2003","unstructured":"Munoz-Pinedo C, Ruiz-Ruiz C, Ruiz de AC, Palacios C, Lopez-Rivas A . Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J Biol Chem 2003; 278: 12759\u201312768.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR26","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1158\/1535-7163.MCT-08-0569","volume":"7","author":"TE Wood","year":"2008","unstructured":"Wood TE, Dalili S, Simpson CD, Hurren R, Mao X, Saiz FS et al. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death. Mol Cancer Ther 2008; 7: 3546\u20133555.","journal-title":"Mol Cancer Ther"},{"key":"BFonc201213_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1139\/o85-049","volume":"63","author":"M Parniak","year":"1985","unstructured":"Parniak M, Kalant N . Incorporation of glucose into glycogen in primary cultures of rat hepatocytes. Can J Biochem Cell Biol 1985; 63: 333\u2013340.","journal-title":"Can J Biochem Cell Biol"},{"key":"BFonc201213_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1476-4598-8-122","volume":"8","author":"H Liu","year":"2009","unstructured":"Liu H, Jiang CC, Lavis CJ, Croft A, Dong L, Tseng HY et al. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2. Mol Cancer 2009; 8: 122.","journal-title":"Mol Cancer"},{"key":"BFonc201213_CR29","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/onc.2009.448","volume":"29","author":"LA Pradelli","year":"2009","unstructured":"Pradelli LA, Beneteau M, Chauvin C, Jacquin MA, Marchetti S, Munoz-Pinedo C et al. Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 2009; 29: 1641\u20131652.","journal-title":"Oncogene"},{"key":"BFonc201213_CR30","doi-asserted-by":"publisher","first-page":"11265","DOI":"10.1158\/0008-5472.CAN-05-2801","volume":"65","author":"M MacFarlane","year":"2005","unstructured":"MacFarlane M, Kohlhaas SL, Sutcliffe MJ, Dyer MJ, Cohen GM . TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. Cancer Res 2005; 65: 11265\u201311270.","journal-title":"Cancer Res"},{"key":"BFonc201213_CR31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/nm1627","volume":"13","author":"KW Wagner","year":"2007","unstructured":"Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL. Nat Med 2007; 13: 1070\u20131077.","journal-title":"Nat Med"},{"key":"BFonc201213_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nchembio.437","volume":"6","author":"K Marino","year":"2010","unstructured":"Marino K, Bones J, Kattla JJ, Rudd PM . A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol 2010; 6: 713\u2013723.","journal-title":"Nat Chem Biol"},{"key":"BFonc201213_CR33","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1074\/jbc.274.9.5654","volume":"274","author":"KM Heiskanen","year":"1999","unstructured":"Heiskanen KM, Bhat MB, Wang HW, Ma J, Nieminen AL . Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J Biol Chem 1999; 274: 5654\u20135658.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","volume":"10","author":"MF van Delft","year":"2006","unstructured":"van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized. Cancer Cell 2006; 10: 389\u2013399.","journal-title":"Cancer Cell"},{"key":"BFonc201213_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1083\/jcb.30.2.269","volume":"30","author":"CR Hackenbrock","year":"1966","unstructured":"Hackenbrock CR . Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J Cell Biol 1966; 30: 269\u2013297.","journal-title":"J Cell Biol"},{"key":"BFonc201213_CR36","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1158\/0008-5472.CAN-10-4531","volume":"71","author":"JL Coloff","year":"2011","unstructured":"Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR et al. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Res 2011; 71: 5204\u20135213.","journal-title":"Cancer Res"},{"key":"BFonc201213_CR37","doi-asserted-by":"publisher","first-page":"e24102","DOI":"10.1371\/journal.pone.0024102","volume":"6","author":"R Yamaguchi","year":"2011","unstructured":"Yamaguchi R, Janssen E, Perkins G, Ellisman M, Kitada S, Reed JC . Efficient elimination of cancer cells by deoxyglucose-ABT-263\/737 combination therapy. PLoS One 2011; 6: e24102.","journal-title":"PLoS One"},{"key":"BFonc201213_CR38","doi-asserted-by":"crossref","unstructured":"Zagorodna O, Martin SM, Rutkowski DT, Kuwana T, Spitz DR, Knudson CM . 2-Deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. Oncogene 2011. Advance online publication, 10 October 2011; doi:10.1038\/onc.2011.454.","DOI":"10.1158\/1538-7445.AM2011-9"},{"key":"BFonc201213_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 2005; 24: 1348\u20131358.","journal-title":"Oncogene"},{"key":"BFonc201213_CR40","doi-asserted-by":"publisher","first-page":"27345","DOI":"10.1074\/jbc.M504019200","volume":"280","author":"M Poukkula","year":"2005","unstructured":"Poukkula M, Kaunisto A, Hietakangas V, Denessiouk K, Katajamaki T, Johnson MS et al. Rapid turnover of c-FLIP short is determined by its unique C-terminal tail. J Biol Chem 2005; 280: 27345\u201327355.","journal-title":"J Biol Chem"},{"key":"BFonc201213_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/j.1460-2075.1994.tb06307.x","volume":"13","author":"R Merino","year":"1994","unstructured":"Merino R, Ding L, Veis DJ, Korsmeyer SJ, Nunez G . Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994; 13: 683\u2013691.","journal-title":"EMBO J"},{"key":"BFonc201213_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1083\/jcb.200912070","volume":"188","author":"B Gillissen","year":"2010","unstructured":"Gillissen B, Wendt J, Richter A, Muer A, Overkamp T, Gebhardt N et al. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma. J Cell Biol 2010; 188: 851\u2013862.","journal-title":"J Cell Biol"},{"key":"BFonc201213_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/onc.2010.466","volume":"30","author":"N El Mjiyad","year":"2011","unstructured":"El Mjiyad N, Caro-Maldonado A, Ramirez-Peinado S, Munoz-Pinedo C . Sugar-free approaches to cancer cell killing. Oncogene 2011; 30: 253\u2013264.","journal-title":"Oncogene"},{"key":"BFonc201213_CR44","first-page":"65","volume":"17","author":"B Chance","year":"1956","unstructured":"Chance B, Williams GR . The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem 1956; 17: 65\u2013134.","journal-title":"Adv Enzymol Relat Subj Biochem"},{"key":"BFonc201213_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ceb.2005.01.006","volume":"2","author":"DG Hardie","year":"2005","unstructured":"Hardie DG . New roles for the LKB1-->AMPK pathway. Curr Opin Cell Biol 2005; 2: 167\u2013173.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc201213_CR46","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/ars.2007.2000","volume":"10","author":"G Benard","year":"2008","unstructured":"Benard G, Rossignol R . Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 2008; 10: 1313\u20131342.","journal-title":"Antioxid Redox Signal"},{"key":"BFonc201213_CR47","first-page":"64:985","volume":"1","author":"R Rossignol","year":"2004","unstructured":"Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA . Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res 2004; 1: 64:985\u201364:993.","journal-title":"Cancer Res"},{"key":"BFonc201213_CR48","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1074\/mcp.M800515-MCP200","volume":"8","author":"RS Boyd","year":"2009","unstructured":"Boyd RS, Jukes-Jones R, Walewska R, Brown D, Dyer MJ, Cain K . Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma. Mol Cell Proteomics 2009; 8: 1501\u20131515.","journal-title":"Mol Cell Proteomics"},{"key":"BFonc201213_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ni.1843","volume":"11","author":"M Capasso","year":"2010","unstructured":"Capasso M, Bhamrah MK, Henley T, Boyd RS, Langlais C, Cain K et al. HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol 2010; 11: 265\u2013272.","journal-title":"Nat Immunol"},{"key":"BFonc201213_CR50","doi-asserted-by":"publisher","first-page":"C125","DOI":"10.1152\/ajpcell.00247.2006","volume":"292","author":"M Wu","year":"2007","unstructured":"Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 2007; 292: C125\u2013CC36.","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFonc201213_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0076-6879(08)01618-2","volume":"446","author":"N Harper","year":"2008","unstructured":"Harper N, MacFarlane M . Recombinant TRAIL and TRAIL receptor analysis. Methods Enzymol 2008; 446: 293\u2013313.","journal-title":"Methods Enzymol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:12:17Z","timestamp":1647886337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,6]]},"references-count":51,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2012,11,29]]}},"alternative-id":["BFonc201213"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.13","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,6]]},"assertion":[{"value":"4 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}